【レポートの概要（一部）】
Table of Contents
Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
1.3 List of Data Sources
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Prostate Cancer Therapeutics Market Variables, Trends & Scope
3.1 Market segmentation& scope
3.1.1 Market Driver Analysis
3.1.1.1 Rising rate of prostate cancer cases
3.1.1.2 Technological advancement in screening and diagnostic tests
3.1.1.3 Rising awareness of prostate cancer
3.1.2 Market Restraint Analysis
3.1.2.1 High cost associated with diagnostic tests and treatment of prostate cancer
3.2 Penetration & Growth Prospect Mapping
3.3 Prostate Cancer Therapeutics Market – PESTLE Analysis
3.4 Industry Analysis – Porter’s
Chapter 4 Prostate Cancer Therapeutics: Drugs Class Estimates & Trend Analysis
4.1 Prostate Cancer Therapeutics Market: Drug Class Movement Analysis
4.2 Hormonal Therapy
4.2.1 Hormonal Therapy Market Estimates & Segment Forecast, 2014 – 2025 (USD Billion)
4.2.2 Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
4.2.2.1 Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists Market Estimates, 2014 – 2025 (USD Billion)
4.2.3 Zytiga
4.2.3.1 Zytiga Market Estimates & Segment Forecast, 2014 – 2025 (USD Billion)
4.2.4 Gonax
4.2.4.1 Gonax Market Estimates & Segment Forecast, 2014 – 2025 (USD Billion)
4.2.5 Luteinizing Hormone-Releasing Hormone (LHRH) Agonists
4.2.5.1 Luteinizing Hormone-Releasing Hormone (LHRH) Agonists Market Estimate & Segment Forecast, 2014 – 2025 (USD Billion)
4.2.6 Lupron
4.2.6.1 Lupron Market Estimate & Segment Forecast, 2014 – 2025 (USD Billion)
4.2.7 Zoladex
4.2.7.1 Zoladex Market Estimate & Segment Forecast, 2014 – 2025 (USD Billion)
4.2.8 Eligard
4.2.8.1 Eligard Market Estimates & Segment Forecast, 2014 – 2025 (USD Billion)
4.2.9 Decapeptyl
4.2.9.1 Decapeptyl Market Estimates & Segment Forecast, 2014 – 2025 (USD Billion)
4.2.10 Vantas
4.2.10.1 Vantas Market Estimates & Segment Forecast, 2014 – 2025 (USD Billion)
4.2.11 Others
4.2.11.1 Others Market Estimates & Segment Forecast, 2014 – 2025 (USD Billion)
4.2.12 Anti-Androgen
4.2.12.1Anti-androgen Market Estimates & Segment Forecast, 2014 – 2025 (USD Billion)
4.2.13 Xtandi
4.2.13.1 Xtandi Market Estimates & Segment Forecast, 2014 – 2025 (USD Billion)
4.2.14 Casodex
4.2.14.1 Casodex Market Estimates & Segment Forecast, 2014 – 2025 (USD Billion)
4.3 Chemotherapy
4.3.1 Chemotherapy Market Estimates & Segment Forecast, 2014 – 2025 (USD Billion)
4.3.2 Taxotere
4.3.2.1 Taxotere Market Estimates, 2014 – 2025 (USD Billion)
4.3.3 Jevtana
4.3.4.1 Jevtana Market Estimates & Segment Forecast, 2014 – 2025 (USD Billion)
4.4 Immunotherapy
4.4.1 Immunotherapy Market Estimates & Segment Forecast, 2014 – 2025 (USD Billion)
4.4.2 Provenge
4.4.2.1 Provenge Market Estimates, 2014 – 2025 (USD Billion)
4.5 Targeted Therapy
4.5.1 Targeted Therapy Market Estimates & Segment Forecast, 2014 – 2025 (USD Billion)
4.5.2 Xofigo
4.5.2.1 Xofigo Market Estimates & Segment Forecast, 2014 – 2025 (USD Billion)
Chapter 5 Prostate Cancer Therapeutics: Regional Estimates & Trend Analysis, by Drug Class
5.1 Prostate Cancer Therapeutics Market Share By Region, 2016 & 2025
5.2 North America
5.2.1 North America prostate cancer therapeutics market estimates & segment forecast, 2014 – 2025 (USD Billion)
5.2.2 U.S.
5.2.2.1 U.S. prostate cancer therapeutics market estimates & segment forecast, 2014 – 2025 (USD Billion)
5.2.3 Canada
5.2.3.1C anada prostate cancer therapeutics market estimates & segment forecast, 2014 – 2025 (USD Billion)
5.3 Europe
5.3.1 Europe prostate cancer therapeutics market estimates & segment forecast, 2014 – 2025 (USD Billion)
5.3.2UK
5.3.2.1 UK prostate cancer therapeutics market estimates & segment forecast, 2014 – 2025 (USD Billion)
5.3.3 Germany
5.3.3.1 Germany prostate cancer therapeutics market estimates & segment forecast, 2014 – 2025 (USD Billion)
5.4 Asia Pacific
5.4.1 Asia Pacific prostate cancer therapeutics market estimates & segment forecast, 2014 – 2025 (USD Billion)
5.4.2 China
5.4.2.1 China prostate cancer therapeutics market estimates & segment forecast, 2014 – 2025 (USD Billion)
5.4.3 Japan
5.4.3.1 Japan prostate cancer therapeutics market estimates & segment forecast, 2014 – 2025 (USD Billion)
5.5 Latin America
5.5.1 Latin America prostate cancer therapeutics market estimates & segment forecast, 2014 – 2025 (USD Billion)
5.5.2 Brazil
5.5.2.1 Brazil prostate cancer therapeutics market estimates & segment forecast, 2014 – 2025 (USD Billion)
5.5.4 Mexico
5.5.4.1 Mexico prostate cancer therapeutics market estimates & segment forecast, 2014 – 2025 (USD Billion)
5.6 MEA
5.6.1 MEA prostate cancer therapeutics market estimates & segment forecast, 2014 – 2025 (USD Billion)
5.6.2 South Africa
5.6.2.1 South Africa prostate cancer therapeutics market estimates & segment forecast, 2014 – 2025 (USD Billion)
Chapter 6 Competitive Landscape
6.1 Company Profiles
6.1.1 Johnson & Johnson
6.1.1.1 Company overview
6.1.1.2 Financial Performance
6.1.1.3 Product benchmarking
6.1.1.4 Strategic initiatives
6.1.2. Astella, Inc.
6.1.2.1 Company overview
6.1.2.2 Financial Performance
6.1.2.3 Product benchmarking
6.1.2.4 Strategic Initiatives
6.1.3 Sanofi Aventis
6.1.3.1 Company overview
6.1.3.2 Financial Performance
6.1.3.3 Product benchmarking
6.1.3.4 Strategic initiatives
6.1.4 IPSEN
6.1.4.1 Company overview
6.1.4.2 Financial Performance
6.1.4.3 Product benchmarking
6.1.4.4 Strategic initiatives
6.1.5 Bayer AG
6.1.5.1 Company overview
6.1.5.2 Financial Performance
6.1.5.3 Product benchmarking
6.1.5.4 Strategic initiatives
6.1.6 Astrazeneca
6.1.6.1 Company overview
6.1.6.2 Financial Performance
6.1.6.3 Product benchmarking
6.1.6.4 Strategic initiatives
6.1.7. Valent Pharmaceuticals LLC
6.1.7.1 Company overview
6.1.7.2 Financial Performance
6.1.7.3 Product benchmarking
6.1.7.4 Strategic initiatives
【レポート販売概要】
■ タイトル：前立腺がん治療薬の世界市場分析：薬別（ザイティガ、ゴナックス、ルプロン、ゾラデックス、デカペプチル、エリガード、ヴァンタス、カソデックス、イクスタンジ、タキソテール、ジェブタナ、プロベンジ、ゾーフィゴ）、地域別、セグメント予測、2014-2025■ 英文：Prostate Cancer Therapeutics Market Analysis By Drugs (Zytiga, Gonax, Lupron, Zoladex, Decapeptyl, Eligard, Vantas, Casodex, Xtandi, Taxotere, Jevtana, Provenge, Xofigo), By Region, And Segment Forecasts, 2014-2025
■ 発行日：2017年5月18日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707718
■ 調査対象地域：グローバル
- Chesapeake Energy Corporation：石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Chesapeake Energy Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Chesapeake Energy Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an …
- 鉄道車両の世界市場：機関車、高速輸送車両、旅客車、貨車The rolling stock market, in terms of value, is projected to grow at a CAGR of 3.68% from 2016 to 2021. The market is estimated to be USD 48.95 Billion in 2016, and is projected to reach 58.66 Billion by 2021. Asia-Oceania is estimated to be the largest market for rolling stock market, followed by Europe and North America. The growth of the rolling stock market is fueled by infrastructural develop …
- 肝性脳症(Hepatic Encephalopathy)：世界の治験レビュー（2015年上半期版）Hepatic Encephalopathy Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Hepatic Encephalopathy Global Clinical Trials Review, H1, 2015" provides data on the Hepatic Encephalopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatic Encephalopathy. It includes an overview of the trial numbers and …
- 腹部脂胖症（Abdominal Obesity）：グローバル臨床試験レビュー（2014年上半期）Abdominal Obesity Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Abdominal Obesity Global Clinical Trials Review, H1, 2014" provides data on the Abdominal Obesity clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Abdominal Obesity. It includes an overview of the trial numbers and their recruitment s …
- 世界の半導体市場動向（～2022）The semiconductor industry is widely recognized as a key driver for economic growth in its role as a multiple lever and technology enabler for the whole electronics value chain. Semiconductors are an essential core of many cutting-edge technological devices varying from smart phones, ultramobiles, flat-screen monitors & television sets to medical devices, civil aerospace and military systems. Alth …
- 世界のエコーウイルス検査市場The report presents a detailed analysis of the Echovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Echovirus definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Comm …
- シリカ（SiO2）鉱石採掘の世界市場2016-2020About Silica Silica (SiO2) is a chemical compound found in the crystalline state. It is used in segments such as glass, hydraulic fracturing, chemicals, and construction. Silica is also used in electronics for applications such as silicon chips. Technavio’s analysts forecast the global silica minerals mining market to grow at a CAGR of 5.09% during the period 2016-2020. [Covered in this report] Th …
- リーシュマニア症(カラアザール病)(Leishmaniasis (Kala-Azar))：世界の治験レビュー（2015年上半期版）Leishmaniasis (Kala-Azar) Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Leishmaniasis (Kala-Azar) Global Clinical Trials Review, H1, 2015" provides an overview of Leishmaniasis (Kala-Azar) clinical trials scenario. This report provides top line data relating to the clinical trials on Leishmaniasis (Kala-Azar). Report includes an overview of trial numbers and …
- 重症虚血肢：治療薬の治験動向（2014年下半期）Critical Limb Ischemia Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Critical Limb Ischemia Global Clinical Trials Review, H2, 2014" provides data on the Critical Limb Ischemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Critical Limb Ischemia. It includes an overview of the trial numbers and …
- 血管内保温システムの世界市場分析：用途別（急性期ケア、周術期ケア）、エンドユーザー別（手術室、ICU、緊急手術室）、地域別、セグメント予測、2014-2025The global intravascular warming systems market is expected to reach a value of USD 565.4 million by 2025, according to a new report by Grand View Research, Inc. Increasing number of surgical procedures is the most significant factor projected to boost the growth of the market during the forecast period. According to the WHO, around 266.2 to 359.5 million surgeries were performed globally in 2012 …
- Mobile? Commerce Solutions and Market OpportunitiesMobile commerce is exploding with solutions, applications, and services driven by emerging technologies, use cases, and business models. M-commerce is quite different from traditional e-commerce as the ecosystem and value chain are more dynamic and are evolving in a different manner than e-commerce as a whole. ? This report bundle is the most comprehensive research covering the market for Mobile C …
- ヨーロッパのCement Clinker市場Cement Clinker: European Union Market Outlook 2012 and Forecast till 2017 provides a complete overview of the market condition. All available data is presented in a comprehensive and easily accessed format. The report provides our Clients with a clear understanding of market current state and future development. Scope The report contains an in-depth analysis of the European Union market for cement …
- 世界の人工心血管置換装置開発動向：医療機器パイプライン分析2015Cardiovascular Prosthetic Devices - Medical Devices Pipeline Assessment, 2015 Summary GlobalData's Medical Devices sector report, “Cardiovascular Prosthetic Devices - Medical Devices Pipeline Assessment, 2015" provides an overview of Cardiovascular Prosthetic Devices currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the …
- 角膜厚測定の世界市場2019-2023Global Corneal Pachymetry Market: About this market Technavio’s corneal pachymetry market analysis considers sales from both non-handheld and hand-held. Our analysis also considers the sales of corneal pachymetry in Asia, Europe, North America, and ROW. In 2018, the non-handheld segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as …
- 4G/LTE基盤のモバイル付加価値サービス（VAS）：市場分析及び予測2013-2018（Mobile Value-added Services (VAS) in 4G: Market Analysis and Forecasts for LTE-based VAS 2013 – 2018）In the pre-LTE marketplace, the biggest mobile value-added services (VAS) are mobile apps and mobile advertising. This does not change simply with the introduction of LTE, as there will only be roughly 184 million LTE subscribers globally against 7.2 billion subs overall by year end 2013. A transformation will occur over a period of years in which certain key mobile VAS applications will establish …
